PATH | VRL
Menu

Find resources

Total results with these characteristics: 67

Disease: Respiratory syncytial virus (RSV)

Page 1 of 4
Acute Respiratory Infections (Update September 2009): Respiratory syncytial virus and parainfluenza viruses

This page on the World Health Organization website provides information on respiratory syncytial virus (RSV) and parainfluenza viruses, including the RSV disease burden, virology, and vaccines under development.

Author: World Health Organization

Publication date: 2009

Advances in RSV Vaccine Research and Development – A Global Agenda

This article, published in Vaccine, provides an overview of respiratory syncytial virus (RSV) disease and outlines the current efforts in vaccine development. It includes the feasibility for an RSV vaccine, constraints to vaccine development, …

Author: Higgins D, Trujillo C, Keech C

Publication date: 2016

Advancing Hope Against Newborn Respiratory Illness

This fact sheet outlines the importance of tackling respiratory syncytial virus (RSV), the top cause of newborn lower respiratory infections worldwide. It highlights the need to prepare for incoming RSV interventions, including vaccines for maternal …

Author: PATH

Publication date: 2016

The Advancing Maternal Immunization Collaboration

This fact sheet outlines the work of the Advancing Maternal Immunization (AMI) collaboration, which brings together diverse stakeholders to improve infant health and survival through maternal immunization. Currently focused on respiratory syncytial …

Author: PATH; World Health Organization

Publication date: 2017

Architecture of Respiratory Syncytial Virus Revealed by Electron Cryotomography

This article, published in the Proceedings of the National Academy of Sciences of the United States of America, describes research to carry out an electron cryotomographic characterization of cell culture-grown human respiratory syncytial virus to …

Author: Liljeroos L, Krzyzaniak MA, Helenius A, Butcher SJ

Publication date: 2013

Biological Challenges and Technological Opportunities for Respiratory Syncytial Virus Vaccine Development

This article, published in Immunological Reviews, provides an overview of the barriers that have challenged and delayed the development of vaccines against respiratory syncytial virus (RSV) and identifies opportunities that could help overcome these …

Author: Graham B

Publication date: 2011

The Bourgeoning Burden of Respiratory Syncytial Virus Among Children

This article, published in Infectious Disorders – Drug Targets, examines the disease burden of respiratory syncytial virus (RSV) in the United States, Canada, and Europe, but notes that the global burden of RSV is unknown as few studies are from …

Author: Hall CB

Publication date: 2012

Center for Vaccine Innovation and Access

This website provides information about the work of PATH’s Center for Vaccine Innovation and Access, which brings together expertise across every stage of vaccine research, development, and introduction to make lifesaving vaccines globally …

Author: PATH

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

This book chapter, published in Current Topics in Microbiology and Immunology, summarizes what is known about the virology, clinical manifestation, immunity, pathogenesis, and epidemiology of respiratory syncytial virus (RSV) as it relates to …

Author: Graham BS, Anderson LJ, eds.

Publication date: 2013

The Changing Landscape of Respiratory Syncytial Virus

Recognition of the high disease burden of respiratory syncytial virus (RSV) has led to increased efforts to prevent and treat RSV. This article, published in Vaccine, attempts to address questions that may emerge using current knowledge from the …

Author: Polack FP

Publication date: 2015

Clinical and Epidemiologic Features of Respiratory Syncytial Virus

This book chapter, published in Current Topics in Microbiology and Immunology, provides an overview of the symptoms and epidemiology for respiratory syncytial virus (RSV) and identifies four potential target populations for a vaccine—infants, …

Author: Hall CB, Simões EAF, Anderson LJ

Publication date: 2013

Clinical Evaluations of Formalin Inactivated RSV Vaccine Candidates in Pediatric Populations During the 1960s (Four Articles)

These articles, published in the American Journal of Epidemiology in 1969, describe results from clinical studies evaluating formalin inactivated respiratory syncytial virus (RSV) vaccine candidates in pediatric populations. All studies found the …

Author: Various

Publication date: 1969

Clinical Presentation and Birth Outcomes Associated With Respiratory Syncytial Virus Infection in Pregnancy

Respiratory syncytial virus (RSV) is the most important cause of viral pneumonia in children worldwide and a maternal vaccine may protect both the mother and infant from RSV illness. This article, published in PLoS ONE, describes the epidemiology …

Author: Chu HY, Katz J, Tielsch J, et al.

Publication date: 2016

Correlates of Immunity to Respiratory Syncytial Virus (RSV) Associated-Hospitalization: Establishment of Minimum Protective Threshold Levels of Serum Neutralizing Antibodies

This article, published in Vaccine, reports on a study to determine if respiratory syncytial virus (RSV) specific, serum antibody titers correlate with protection against RSV-associated hospitalization at all ages. The authors identified a minimal …

Author: Piedra PA, Jewell AM, Cron SG, Atmar RL, Glezen WP

Publication date: 2003

Cross-Neutralization of Four Paramyxoviruses by a Human Monoclonal Antibody

This article, published in Nature, reports the results of a study describing a human monoclonal antibody that potentially cross-neutralizes human respiratory syncytial virus (RSV) along with three other viruses of different species. The results …

Author: Corti D, Bianchi S, Vanzetta F, et al.

Publication date: 2013

Disease Control Priorities, Third Edition: Volume 2. Reproductive, Maternal, Newborn, and Child Health

This book focuses on maternal conditions, childhood illness, and malnutrition. Specifically, the chapters address acute illness and undernutrition in children, principally under age five. Of particular interest may be chapters 9, 10, and 19, which …

Author: Black RE, Laxminarayan R, Temmerman M, Walker N, eds.

Publication date: 2016

Epidemiology, Aetiology and Management of Childhood Acute Community-Acquired Pneumonia in Developing Countries--A Review

This article, published in the African Journal of Medicine and Medical Sciences, provides an overview of the causes of clinical pneumonia in developing countries, available vaccines for fighting pneumonia, and efforts underway and planned to expand …

Author: Falade AG, Ayede AI

Publication date: 2011

Estimating the Full Public Health Value of Vaccination

This conference report, published in Vaccine, builds upon a discussion in the public health community on how to assess and incorporate, in addition to safety and measures of protective efficacy, the full public health value (FPHV) of preventive …

Author: Gessner BD, Kaslow D, Louis J, et al.

Publication date: 2017

Evaluating Vaccination Strategies for Reducing Infant Respiratory Syncytial Virus Infection in Low-Income Settings

Infants account for the majority of severe respiratory syncytial virus (RSV) burden, but they are a problematic RSV vaccine target population due to their immunological immaturity. This article, published in BMC Medicine, reports on a study that …

Author: Poletti P, Merler S, Ajelli M, et al.

Publication date: 2015

Global Burden of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Young Children: A Systematic Review and Meta-analysis

This article, published in The Lancet, describes research to estimate the global incidence of and mortality from episodes of acute lower respiratory infection (ALRI) due to respiratory syncytial virus (RSV) in children younger than five years …

Author: Nair H, Nokes DJ, Gessner BD, et al.

Publication date: 2010

Page 1 of 4